Viewing nowCombinationBonamax Plus D Tablet
Sodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.

MFDS item code 201203101 · Approved 2012.04.23 · Insurance code 644308330
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in postmenopausal women and men.
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Discontinuation should be considered after 3~5 years of treatment in patients at low risk of fracture. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages, foods, and medicines, including mineral water and barley tea, may reduce the absorption of alendronate (see “Drug Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it, and remain upright until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get enough calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides the equivalent of one week’s supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Use in elderly patients (65 years and older): No dose adjustment is necessary. Use in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.
Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.
This medication may cause irritation to the gastrointestinal tract, particularly the esophagus, which can lead to problems such as esophagitis, esophageal ulcers, and esophageal erosions. If these symptoms occur, discontinue use immediately and consult a physician. When taking this medication, it should be taken with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking it. This helps to reduce the risk of side effects by ensuring the medication does not remain in the esophagus for too long. Patients with esophageal diseases or upper gastrointestinal disorders such as gastritis, duodenitis, or ulcers should use this medication cautiously. Patients with esophageal strictures, achalasia, hypocalcemia, and those allergic to any ingredient in this medication should not be administered this drug. Additionally, patients with certain genetic conditions should not use this medication if it contains lactose. Common gastrointestinal adverse reactions may include abdominal pain, nausea, dyspepsia, constipation, and diarrhea, as well as musculoskeletal pain, headache, and dizziness. Rarely, prolonged use may lead to osteonecrosis of the jaw or severe musculoskeletal pain, so consult a physician if unusual symptoms occur. Calcium or vitamin D deficiencies should be supplemented, and patients at high risk of vitamin D deficiency should consider taking additional supplements. This medication may pose risks to the fetus during pregnancy, hence women who are pregnant or may become pregnant should consult a physician before taking it. Nursing women also need to exercise caution when taking this medication, and it is not recommended for children. This medication is not recommended for patients with severely impaired renal function. There may be interactions with other medications, especially calcium supplements, antacids, aspirin, and non-steroidal anti-inflammatory drugs, so it is necessary to space out the doses. In case of overdose, symptoms of hypocalcemia or gastrointestinal irritation may occur, and one should contact a medical institution immediately for appropriate actions. Finally, keep this medication out of reach of children and be careful not to transfer it to other containers.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, esophageal ulcer, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, taste disturbances, rash, erythema, anastomotic ulcer, hives, angioedema, hypersensitivity reaction, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized jawbone necrosis, joint edema, low-energy fractures of the femoral head and other bones, dizziness, vertigo, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external ear canal, nasopharyngitis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it should be kept away from direct sunlight and stored at room temperature between 1°C and 30°C.
White to grayish-white rectangular tablets, one side engraved with UT, and the other side depicting a bone.
4 tablets (4 tablets/PTPX1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.